AN OPEN LABEL, MULTICENTER, EXTENSION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PADSEVONIL AS ADJUNCTIVE TREATMENT OF FOCAL-ONSET SEIZURES IN ADULT SUBJECTS WITH DRUG-RESISTANT EPILEPSY
- Registry ID
- EP0093
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- UCB INC
- Start date
- 2019-01-21
- Completion date
- 2020-08-26
- Last update
- 2018-03-23
Conditions
- EPILEPSY
- FOCAL-ONSET SEIZURES
Related clinical trials
- A PHASE 3, OPEN-LABEL STUDY TO INVESTIGATE THE LONG-TERM SAFETY AND EFFICACY OF
LP352 IN THE TREATMENT OF SEIZURES IN CHILDREN AND ADULTS WITH DEVELOPMENTAL
AND EPILEPTIC ENCEPHALOPATHY
- A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF LP352 IN THE TREATMENT OF SEIZURES IN CHILDREN AND ADULTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES
- FERUMOXYTOL ENHANCED HIPPOCAMPAL VASCULAR IMAGING IN EPILEPSY
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF XEN1101 AS ADJUNCTIVE THERAPY IN PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
- AN OPEN-LABEL EXTENSION STUDY OF XEN496 IN PEDIATRIC SUBJECTS WITH KCNQ2 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
- FLUNARIZINE FOR TREATMENT RESISTANT ABSENCE EPILEPSY
View on source registry